Max Healthcare Institute Q1 Results FY27: Uniresearch Prediction and Analysis

Max Healthcare Institute Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Max Healthcare Institute Q1 FY27 Revenue Rs 2,665 Cr (+31.4% YoY) and PAT Rs 402 Cr (+30.5% YoY). Prepared by Kunal Singla.

Click Here – Get Free Investment Predictions

Max Healthcare Institute Q1 Results FY27 – Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 FY27 Uniresearch Prediction	YoY Change	Source
Max Healthcare Institute Revenue (Rs Cr)	2,028	2,665	+31.4%	Uniresearch | Uniresearch trailing analysis
PAT (Rs Cr)	308	402	+30.5%	Uniresearch | Uniresearch trailing analysis
Avg Analyst Target	See screener	12-month view	–	Uniresearch trailing analysis

Max Healthcare Institute Q4 FY26 Performance

Metric	Q4 FY26 Actual	vs Q1 FY26	Source
Revenue (Rs Cr)	2,143	+5.7%	Screener consolidated
PAT (Rs Cr)	342	+11.0%	Screener consolidated

Analyst Views and Growth Outlook

The Uniresearch trailing analysis projects Max Healthcare Institute FY27 revenue at +31.4% and profit at +30.5% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Max Healthcare Institute delivering revenue of Rs 2,143 Cr and PAT of Rs 342 Cr.

Key Watchpoints

Revenue Delivery

Key question: can Max Healthcare Institute reach Rs 2,665 Cr in Q1 FY27 revenue, representing +31.4% YoY growth over the Q1 FY26 base of Rs 2,028 Cr.

PAT vs Growth Target

Profit performance of Rs 402 Cr (+30.5%) vs the Q1 FY26 base of Rs 308 Cr is the profitability watchpoint for Max Healthcare Institute in Q1 FY27.

Risks

Revenue Shortfall

Revenue below the +31.4% consensus would indicate sector headwinds or execution delays for Max Healthcare Institute.

Margin Pressure

Cost increases or margin compression could challenge the +30.5% PAT growth projection for Max Healthcare Institute in Q1 FY27.

Conclusion

The Max Healthcare Institute Q1 FY27 Uniresearch projection of Revenue Rs 2,665 Cr and PAT Rs 402 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Max Healthcare Institute live on the Univest Screener.

Track Max Healthcare Institute Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live FY27 alerts.

FAQs on Max Healthcare Institute Q1 Results FY27

What is Uniresearch’s PAT prediction for Max Healthcare Institute Q1 Results FY27?

Ans. Uniresearch projects Max Healthcare Institute Q1 FY27 PAT at Rs 402 Cr (+30.5% vs Q1 FY26 base Rs 308 Cr).

What is the Revenue forecast for Max Healthcare Institute Q1 Results FY27?

Ans. Max Healthcare Institute Q1 FY27 Revenue is projected at Rs 2,665 Cr (+31.4% consensus).

What were Max Healthcare Institute Q4 FY26 actuals for Max Healthcare Institute Q1 Results FY27?

Ans. Q4 FY26 Revenue Rs 2,143 Cr and PAT Rs 342 Cr.

How many analysts cover Max Healthcare Institute Q1 Results FY27?

Ans. The prediction uses Uniresearch trailing analysis, avg target Rs 0.

What consensus applies to Max Healthcare Institute Q1 Results FY27?

Ans. Revenue +31.4% and profit +30.5% (Uniresearch trailing analysis).

What are the main risks to Max Healthcare Institute Q1 Results FY27?

Ans. Revenue missing +31.4% consensus and PAT pressure vs +30.5% growth target.

What is the Q1 FY26 base for Max Healthcare Institute Q1 Results FY27?

Ans. Q1 FY26 Revenue Rs 2,028 Cr and PAT Rs 308 Cr.